North America Clinical Trial Imaging Market – Industry Trends and Forecast to 2026

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF NORTH AMERICA CLINICAL TRIAL IMAGING MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET: GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.7 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET: DBMR MARKET POSITION GRID

2.8 DBMR VENDOR SHARE ANALYSIS

2.9 MULTIVARIATE MODELING

2.10 PRODUCTS LIFELINE CURVE

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.1.1 RISING R&D EXPENDITURE

3.1.2 INCREASING NUMBER OF CONTRACT RESEARCH ORGANIZATION

3.1.3 INCREASING PREVALENCE OF CHRONIC DISEASES

3.1.4 GROWTH IN THE PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES

3.2 RESTRAINTS

3.2.1 HIGH RISK RADIATION CAUSING DISEASES

3.2.2 HIGH IMPLEMENTATION COST OF IMAGING SYSTEMS

3.3 OPPORTUNITIES

3.3.1 STRATEGIC INITIATIVES FOR BUSINESS EXPANSION

3.3.2 DEVELOPMENT OF INNOVATIVE IMAGING MODALITIES AND CONTRAST AGENTS

3.3.3 EMERGING ECONOMIES

3.4 CHALLENGES

3.4.1 STRICT REGULATORY POLICIES

3.4.2 COST OF CLINICAL TRIALS

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 NORTH AMERICA CLINICAL TRIAL IMAGINGMARKET, BY PRODUCT AND SERVICES

6.1 OVERVIEW

6.2 SERVICES

6.2.1 OPERATIONAL IMAGING SERVICES

6.2.2 READ ANALYSIS SERVICES

6.2.3 TRIAL DESIGN CONSULTING SERVICES

6.2.4 SYSTEM AND TECHNICAL SUPPORT SERVICES

6.3 SOFTWARE

7 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET, BY APPLICATION

7.1 OVERVIEW

7.2 ONCOLOGY

7.2.1 ECHOCARDIOGRAPHY

7.2.2 MAGNETIC RESONANCE IMAGING

7.2.3 COMPUTED TOMOGRAPHY

7.2.4 POSITRON EMISSION TOMOGRAPHY

7.2.5 NUCLEAR MEDICINE

7.2.6 X-RAY

7.2.7 ULTRASOUND

7.2.8 OPTICAL COHERENCE TOMOGRAPHY

7.2.9 OTHERS

7.3 NEUROLOGY

7.3.1 COMPUTED TOMOGRAPHY

7.3.2 MAGNETIC RESONANCE IMAGING

7.3.3 POSITRON EMISSION TOMOGRAPHY

7.3.4 NUCLEAR MEDICINE

7.3.5 X-RAY

7.3.6 ULTRASOUND

7.3.7 OPTICAL COHERENCE TOMOGRAPHY

7.3.8 OTHERS

7.4 ENDOCRINOLOGY

7.4.1 COMPUTED TOMOGRAPHY

7.4.2 MAGNETIC RESONANCE IMAGING

7.4.3 POSITRON EMISSION TOMOGRAPHY

7.4.4 NUCLEAR MEDICINE

7.4.5 X-RAY

7.4.6 ULTRASOUND

7.4.7 OPTICAL COHERENCE TOMOGRAPHY

7.4.8 OTHERS

7.5 CARDIOLOGY

7.5.1 X-RAY

7.5.2 ULTRASOUND

7.5.3 COMPUTED TOMOGRAPHY

7.5.4 MAGNETIC RESONANCE IMAGING

7.5.5 NUCLEAR MEDICINE

7.5.6 POSITRON EMISSION TOMOGRAPHY

7.5.7 OPTICAL COHERENCE TOMOGRAPHY

7.5.8 ECHOCARDIOGRAPHY

7.5.9 OTHERS

7.6 DERMATOLOGY

7.6.1 ULTRASOUND

7.6.2 X-RAY

7.6.3 MAGNETIC RESONANCE IMAGING

7.6.4 COMPUTED TOMOGRAPHY

7.6.5 OPTICAL COHERENCE TOMOGRAPHY

7.6.6 POSITRON EMISSION TOMOGRAPHY

7.6.7 NUCLEAR MEDICINE

7.6.8 OTHERS

7.7 HEMATOLOGY

7.7.1 ULTRASOUND

7.7.2 COMPUTED TOMOGRAPHY

7.7.3 MAGNETIC RESONANCE IMAGING

7.7.4 X-RAY

7.7.5 POSITRON EMISSION TOMOGRAPHY

7.7.6 NUCLEAR MEDICINE

7.7.7 OPTICAL COHERENCE TOMOGRAPHY

7.7.8 ECHOCARDIOGRAPHY

7.7.9 OTHERS

8 NORTH AMERICA CLINICAL TRIAL IMAGINGMARKET, BY MODALITY

8.1 OVERVIEW

8.2 COMPUTED TOMOGRAPHY

8.3 MAGNETIC RESONANCE IMAGING

8.4 ULTRASOUND

8.5 POSITRON EMISSION TOMOGRAPHY

8.6 X-RAY

8.7 ECHOCARDIOGRAPHY

8.8 NUCLEAR MEDICINE

8.9 OPTICAL COHERENCE TOMOGRAPHY

8.10 OTHERS

9 NORTH AMERICA CLINICAL TRIAL IMAGINGMARKET, BY END USER

9.1 OVERVIEW

9.2 CONTRACT RESEARCH ORGANIZATION

9.3 MEDICAL DEVICE MANUFACTURERS

9.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

9.5 ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES

10 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET, BY DISTRIBUTOR

10.1 OVERVIEW

10.2 DIRECT SALES

10.3 TENDERS SALES

11 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET, BY GEOGRAPHY

11.1 NORTH AMERICA

11.1.1 U.S.

11.1.2 CANADA

11.1.3 MEXICO

12 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET, COMPANY LANDSCAPE

12.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

13 COMPANY PROFILE

13.1 NAVITAS LIFE SCIENCES

13.1.1 COMPANY SNAPSHOT

13.1.2 REVENUE ANALYSIS

13.1.3 COMPANY SHARE ANALYSIS

13.1.4 SERVICE PORTFOLIO

13.1.5 RECENT DEVELOPMENTS

13.2 RESONANCE HEALTH

13.2.1 COMPANY SNAPSHOT

13.2.2 REVENUE ANALYSIS

13.2.3 COMPANY SHARE ANALYSIS

13.2.4 SERVICE PORTFOLIO

13.2.5 RECENT DEVELOPMENTS

13.3 BIOTELEMETRY, INC.

13.3.1 COMPANY SNAPSHOT

13.3.2 REVENUE ANALYSIS

13.3.3 COMPANY SHARE ANALYSIS

13.3.4 SERVICEPORTFOLIO

13.3.5 RECENT DEVELOPMENTS

13.4 IXICO PLC

13.4.1 COMPANY SNAPSHOT

13.4.2 REVENUE ANALYSIS

13.4.3 COMPANY SHARE ANALYSIS

13.4.4 SERVICE PORTFOLIO

13.4.5 RECENT DEVELOPMENTS

13.5 ICON PLC

13.5.1 COMPANY SNAPSHOT

13.5.2 REVENUE ANALYSIS

13.5.3 COMPANY SHARE ANALYSIS

13.5.4 SERVICE PORTFOLIO

13.5.5 RECENT DEVELOPMENTS

13.6 IMAGE CORE LAB

13.6.1 COMPANY SNAPSHOT

13.6.2 SERVICE PORTFOLIO

13.6.3 RECENT DEVELOPMENT

13.7 ANAGRAM 4 CLINICAL TRIALS

13.7.1 COMPANY SNAPSHOT

13.7.2 SERVICE PORTFOLIO

13.7.3 RECENT DEVELOPMENT

13.8 BIOCLINICA

13.8.1 COMPANY SNAPSHOT

13.8.2 SERVICE PORTFOLIO

13.8.3 RECENT DEVELOPMENTS

13.9 CARDIOVASCULAR IMAGING TECHNOLOGIES

13.9.1 COMPANY SNAPSHOT

13.9.2 PRODUCT PORTFOLIO

13.9.3 RECENT DEVELOPMENT

13.10 ERT CLINICAL

13.10.1 COMPANY SNAPSHOT

13.10.2 SERVICE PORTFOLIO

13.10.3 RECENT DEVELOPMENTS

13.11 INTRINSIC IMAGING

13.11.1 COMPANY SNAPSHOT

13.11.2 PRODUCT PORTFOLIO

13.11.3 SERVICE PORTFOLIO

13.11.4 RECENT DEVELOPMENTS

13.12 LYSCAUT MEDICAL IMAGING COMPANY

13.12.1 COMPANY SNAPSHOT

13.12.2 SERVICE PORTFOLIO

13.12.3 RECENT DEVELOPMENT

13.13 PAREXEL INTERNATIONAL CORPORATION

13.13.1 COMPANY SNAPSHOT

13.13.2 SERVICE PORTFOLIO

13.13.3 RECENT DEVELOPMENTS

13.14 PERSPECTUM DIAGNOSTICS

13.14.1 COMPANY SNAPSHOT

13.14.2 PRODUCT PORTFOLIO

13.14.3 SERVICE PORTFOLIO

13.14.4 RECENT DEVELOPMENTS

13.15 QUOTIENT SCIENCES

13.15.1 COMPANY SNAPSHOT

13.15.2 SERVICE PORTFOLIO

13.15.3 RECENT DEVELOPMENTS

13.16 RADIANT SAGE LLC

13.16.1 COMPANY SNAPSHOT

13.16.2 PRODUCT PORTFOLIO

13.16.3 SERVICE PORTFOLIO

13.16.4 RECENT DEVELOPMENTS

13.17 WORLDCARE CLINICAL

13.17.1 COMPANY SNAPSHOT

13.17.2 SERVICE PORTFOLIO

13.17.3 RECENT DEVELOPMENTS

14 QUESTIONNAIRE

15 RELATED REPORTS

UU

TABLE 1 COST OF CLINICAL TRIAL PHASE 2 AND PHASE 3

TABLE 2 HUGE R&D COST IN THE U.S. FOR DIFFERENT PHASES

TABLE 3 NORTH AMERICA CLINICAL TRIAL IMAGINGMARKET, BY PRODUCT AND SERVICES, 2017-2026 (USD MILLION)

TABLE 4 NORTH AMERICA SERVICES IN CLINICAL TRIAL IMAGING MARKET,BY REGION, 2017-2026 (USD MILLION)

TABLE 5 NORTH AMERICA SERVICES IN CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 6 NORTH AMERICA SOFTWARE CLINICAL TRIAL IMAGING MARKET,BY REGION, 2017-2026 (USD MILLION)

TABLE 7 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 8 ONCOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 9 NORTH AMERICA ONCOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 10 NORTH AMERICA NEUROLOGY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 11 NORTH AMERICA NEUROLOGYI N CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 12 NORTH AMERICA ENDOCRINOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 13 NORTH AMERICA ENDOCRINOLOGY CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 14 NORTH AMERICA CARDIOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 15 NORTH AMERICA CARDIOLOGY CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 16 NORTH AMERICA DERMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 17 NORTH AMERICA DERMATOLOGY CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 18 NORTH AMERICA HEMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 19 NORTH AMERICA HEMATOLOGY CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 20 NORTH AMERICA CLINICAL TRIAL IMAGINGMARKET, BY MODALITY, 2017-2026 (USD MILLION)

TABLE 21 NORTH AMERICA COMPUTED TOMOGRAPHY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 22 NORTH AMERICA MAGNETIC RESONANCE IMAGING IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 23 NORTH AMERICA ULTRASOUND IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 24 NORTH AMERICA POSITRON EMISSION TOMOGRAPHY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 25 NORTH AMERICA X-RAY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 26 NORTH AMERICA ECHOCARDIOGRAPHY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 27 NORTH AMERICA NUCLEAR MEDICINE IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 28 NORTH AMERICA OPTICAL COHERENCE TOMOGRAPHYIN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 29 NORTH AMERICA OTHERS SEGMENTS IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 30 NORTH AMERICA CLINICAL TRIAL IMAGINGMARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 31 NORTH AMERICA BIOTECHNOLOGY COMPANIES IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 32 NORTH AMERICA MEDICAL DEVICE MANUFACTURERS COMPANIES IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 33 NORTH AMERICA PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 34 NORTH AMERICA ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES IN CLINICAL TRIAL IMAGINGMARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 35 NORTH AMERICA CLINICAL TRIAL IMAGINGMARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 36 NORTH AMERICA DIRECT SALES IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 37 NORTH AMERICA TENDERS SALES IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 38 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET,BY COUNTRY, 2017-2026 (USD MILLION)

TABLE 39 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 40 NORTH AMERICA SERVICES IN CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 41 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2017-2026 (USD MILLION)

TABLE 42 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 43 NORTH AMERICA ONCOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 44 NORTH AMERICA NEUROLOGY CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 45 NORTH AMERICA ENDOCRINOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION,2017-2026 (USD MILLION)

TABLE 46 NORTH AMERICA CARDIOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 47 NORTH AMERICA DERMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 48 NORTH AMERICA HEMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 49 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 50 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET, BY DISTRIBUTOR, 2017-2026 (USD MILLION)

TABLE 51 U.S CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 52 U.S SERVICES IN CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 53 U.S CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2017-2026 (USD MILLION)

TABLE 54 U.S CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 55 U.S ONCOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 56 U.S NEUROLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 57 U.S ENDOCRINOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 58 U.S CARDIOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 59 U.S DERMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 60 U.S HEMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 61 U.S CLINICAL TRIAL IMAGING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 62 U.S CLINICAL TRIAL IMAGING MARKET, BY DISTRIBUTOR, 2017-2026 (USD MILLION)

TABLE 63 CANADA CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 64 CANADA SERVICES IN CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 65 CANADA CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2017-2026 (USD MILLION)

TABLE 66 CANADA CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 67 CANADA ONCOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 68 CANADA NEUROLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 69 CANADA ENDOCRINOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 70 CANADA CARDIOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 71 CANADA DERMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 72 CANADA HEMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 73 CANADA CLINICAL TRIAL IMAGING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 74 CANADA CLINICAL TRIAL IMAGING MARKET, BY DISTRIBUTOR, 2017-2026 (USD MILLION)

TABLE 75 MEXICO CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 76 MEXICO SERVICES IN CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 77 MEXICO CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2017-2026 (USD MILLION)

TABLE 78 MEXICO CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 79 MEXICO ONCOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 80 MEXICO NEUROLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 81 MEXICO ENDOCRINOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 82 MEXICO CARDIOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 83 MEXICO DERMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 84 MEXICO HEMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 85 MEXICO CLINICAL TRIAL IMAGING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 86 MEXICO CLINICAL TRIAL IMAGING MARKET, BY DISTRIBUTOR, 2017-2026 (USD MILLION)